Institutional Ownership Royalty Pharma PLC (RPRX)
This table provides information about the institutional ownership of Royalty Pharma PLC (RPRX). We have compiled data on the 497 institutions that hold shares in the stock, with a total of 306 Million shares, which have been reported (via 13F filing form) to have a value of $11 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
46,604,103
shares
|
$1.67 Billion
0.11% of portfolio
|
Q2 2025
Added 13.59%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
36,377,678
shares
|
$1.3 Billion
0.02% of portfolio
|
Q2 2025
Reduced 0.82%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
23,017,561
shares
|
$825 Million
0.01% of portfolio
|
Q2 2024
Added 8.54%
|
|
|
Capital International Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
21,880,620
shares
|
$785 Million
0.14% of portfolio
|
Q2 2025
New holding
|
|
|
Baillie Gifford & CO
|
Aug 06, 2025 Q2 2025 |
18,020,455
shares
|
$646 Million
0.51% of portfolio
|
Q2 2025
Added 34.46%
|
|
|
Swedbank Ab
Stockholm, V7 |
Jul 10, 2025 Q2 2025 |
12,157,470
shares
|
$436 Million
0.51% of portfolio
|
Q1 2025
Reduced 0.06%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
10,194,938
shares
|
$366 Million
0.01% of portfolio
|
Q2 2025
Added 7.13%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
8,176,504
shares
|
$293 Million
0.02% of portfolio
|
Q2 2025
Added 2.21%
|
|
|
Caledonia (Private) Investments Pty LTD
Sydney Nsw, C3 |
Aug 14, 2025 Q2 2025 |
6,444,729
shares
|
$231 Million
5.9% of portfolio
|
Q2 2025
Added 26.01%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
6,000,000
shares
|
$215 Million
0.38% of portfolio
|
Q2 2025
Reduced 4.0%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
5,034,369
shares
|
$181 Million
0.02% of portfolio
|
Q2 2025
New holding
|
|
|
Victory Capital Management Inc
|
Aug 13, 2025 Q2 2025 |
4,491,680
shares
|
$161 Million
0.11% of portfolio
|
Q2 2025
Added 23.97%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
4,076,999
shares
|
$146 Million
0.03% of portfolio
|
Q2 2025
Added 43.16%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
4,021,850
shares
|
$144 Million
0.02% of portfolio
|
Q2 2025
Added 35.13%
|
|
|
Siguler Guff Advisers, LLC
|
Feb 15, 2023 Q4 2022 |
3,391,754
shares
|
$122 Million
64.43% of portfolio
|
Q4 2022
Reduced 49.84%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
3,008,837
shares
|
$108 Million
0.02% of portfolio
|
Q2 2025
Reduced 3.64%
|
|
|
Patient Capital Management, LLC
Baltimore, MD |
Aug 13, 2025 Q2 2025 |
2,987,988
shares
|
$107 Million
5.66% of portfolio
|
Q2 2025
Added 0.52%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
2,976,480
shares
|
$107 Million
0.08% of portfolio
|
Q2 2025
Added 118.73%
|
|
|
New South Capital Management Inc
Memphis, TN |
Aug 13, 2025 Q2 2025 |
2,886,569
shares
|
$104 Million
5.65% of portfolio
|
Q2 2025
Reduced 0.72%
|
|
|
Amundi
Paris, I0 |
Aug 13, 2025 Q2 2025 |
2,797,471
shares
|
$100 Million
0.04% of portfolio
|
Q2 2025
Added 126.08%
|
|
|
Legal & General Group PLC
London, X0 |
Aug 12, 2025 Q2 2025 |
2,719,093
shares
|
$97.5 Million
0.03% of portfolio
|
Q2 2025
Reduced 3.27%
|
|
|
Viking Global Investors LP
|
Aug 14, 2025 Q2 2025 |
2,597,460
shares
|
$93.1 Million
0.3% of portfolio
|
Q2 2025
Reduced 75.41%
|
|
|
Jupiter Asset Management LTD
|
Aug 08, 2025 Q2 2025 |
2,470,706
shares
|
$88.6 Million
0.8% of portfolio
|
Q2 2025
Added 126.55%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
2,206,765
shares
|
$79.1 Million
0.01% of portfolio
|
Q2 2025
Added 63.16%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
2,041,344
shares
|
$73.2 Million
0.01% of portfolio
|
Q2 2025
Reduced 49.29%
|